International Multicentre Study of Candida auris Infections
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Background:Candida auris has emerged globally as a multi-drug resistant yeast and is commonly associated with nosocomial outbreaks in ICUs. Methods: We conducted a retrospective observational multicentre study to determine the epidemiology of C. auris infections, its management strategies, patient outcomes, and infection prevention and control practices across 10 centres from five countries. Results: Significant risk factors for C. auris infection include the age group of 61–70 years (39%), recent history of ICU admission (63%), diabetes (63%), renal failure (52%), presence of CVC (91%) and previous history of antibiotic treatment (96%). C. auris was commonly isolated from blood (76%). Echinocandins were the most sensitive drugs. Most common antifungals used for treatment were caspofungin (40%), anidulafungin (28%) and micafungin (15%). The median duration of treatment was 20 days. Source removal was conductedin 74% patients. All-cause crude mortality rate after 30 days was 37%. Antifungal therapy was associated with a reduction in mortality (OR:0.27) and so was source removal (OR:0.74). Contact isolation precautions were followed in 87% patients. Conclusions:C. auris infection carries a high risk for associated mortality. The organism is mainly resistant to most azoles and even amphotericin-B. Targeted antifungal therapy, mainly an echinocandin, and source control are the prominent therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-drug resistant Candida infections are on the rise due to a variety of mechanisms (Table 2), particularly C. auris, with widespread azole resistance and the potential for development of resistance to all classes of antifungals during therapy, highlighting the need for new agents to keep up with changes in epidemiology.133,145–153”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [152]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Candida auris: an Emerging Fungal Pathogen
Spivak, E. S., & Hanson, K. E. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01588-17 · Cited by 393
Candida auris candidaemia in Indian ICUs: analysis of risk factors
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · cited 1×
“Other common clinical conditions include urinary tract infection, otitis, surgical wound infections, skin abscesses, peritonitis and wound infections [16,17].”
BackgroundOsei Sekyere, J. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.578 · Cited by 300
Arendrup, M. C., Prakash, A., Meletiadis, J., Sharma, C., & Chowdhary, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00485-17 · Cited by 270
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
Ostrowsky, B., Greenko, J., Adams, E., Quinn, M., O’Brien, B., Chaturvedi, V., Berkow, E., Vallabhaneni, S., Forsberg, K., Chaturvedi, S., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6901a2 · Cited by 246
Invasive Infections with Multidrug-Resistant Yeast Candida auris , Colombia
Morales-López, S. E., Parra-Giraldo, C. M., Ceballos-Garzón, A., Martínez, H. P., Rodríguez, G. J., Álvarez-Moreno, C. A., & Rodríguez, J. Y. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2301.161497 · Cited by 243
Can Multidrug-Resistant Candidaauris Be Reliably Identified in Clinical Microbiology Laboratories?
Mizusawa, M., Miller, H., Green, R., Lee, R., Durante, M., Perkins, R., Hewitt, C., Simner, P. J., Carroll, K. C., Hayden, R. T., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02202-16 · Cited by 217
Multidrug-resistant Candida auris: ‘New kid on the block’ in hospital-associated infections?
Chowdhary, A., Voss, A., & Meis, J. F. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.004 · Cited by 214 · cited 1×
“auris infections has been shown to be beneficial, as earlier initiation of appropriate antifungal therapy saved many lives [15].”
BackgroundCandida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
Chen, J., Tian, S., Han, X., Chu, Y., Wang, Q., Zhou, B., & Shang, H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05543-0 · Cited by 159
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Sarma, S., & Upadhyay, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s116229 · Cited by 146
Surface disinfection challenges for Candida auris: an in-vitro study
Kean, R., Sherry, L., Townsend, E., McKloud, E., Short, B., Akinbobola, A., Mackay, W. G., Williams, C., Jones, B. L., & Ramage, G. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.015 · Cited by 125
Identification of Drug Resistant Candida auris
Kordalewska, M., & Perlin, D. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01918 · Cited by 124
Shastri, P. S., Shankarnarayan, S. A., Oberoi, J., Rudramurthy, S. M., Wattal, C., & Chakrabarti, A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.01.004 · Cited by 103
Candida auris Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing
Ledwoch, K., & Maillard, J.-Y. (2018) · Materials · doi:10.3390/ma12010018 · Cited by 94
Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
Fasciana, T., Cortegiani, A., Ippolito, M., Giarratano, A., Diquattro, O., Lipari, D., Graceffa, D., & Giammanco, A. (2020) · Antibiotics · doi:10.3390/antibiotics9110778 · Cited by 84
Self-citationSayeed, M. A., Farooqi, J., Jabeen, K., Awan, S., & Mahmood, S. F. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3999-y · Cited by 76
Erdem, H., İnan, A., Altındiş, S., Carević, B., Askarian, M., Cottle, L. E., Beovič, B., Csomós, Á., Metodiev, K., Ahmetagić, S., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.001 · Cited by 54
Self-citationArensman, K., Miller, J. L., Chiang, A., Mai, N., Levato, J., LaChance, E., Anderson, M., Beganovic, M., & Dela Pena, J. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.191588 · Cited by 52
Candida auris Urinary Tract Infections and Possible Treatment
Griffith, N. C., & Danziger, L. H. (2020) · Antibiotics · doi:10.3390/antibiotics9120898 · Cited by 48
Wang, T. Z., White, K. N., Scarr, J. V., Simon, M. S., & Calfee, D. P. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.01.021 · Cited by 13
(2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy333 · Cited by 7
Cited by
The importance of antimicrobial resistance in medical mycology
Gow, N. A. R., Johnson, C., Berman, J., Coste, A. T., Cuomo, C. A., Perlin, D. S., Bicanic, T., Harrison, T. S., Wiederhold, N., Bromley, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32249-5 · Cited by 224
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Kim, H. Y., Nguyen, T. A., Kidd, S. E., Chambers, J., Alastruey‐Izquierdo, A., Shin, J.-H., Dao, A., Forastiero, A., Wahyuningsih, R., Chakrabarti, A., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae042 · Cited by 123
Update on the Pathogenesis, Virulence, and Treatment of Candida auris
Watkins, R. R., Gowen, R., Lionakis, M., & Ghannoum, M. (2022) · Pathogens and Immunity · doi:10.20411/pai.v7i2.535 · Cited by 68
“auris infections was 61 to 70 years [25].”
BackgroundBaldim, I., Paziani, M. H., Barião, P. H. G., Kress, M. R. V. Z., & OLIVEIRA, W. P. D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010180 · Cited by 53
Metadata
- Authors
- Pandya, N., Cag, Y., Pandak, N., Pekok, A. U., Poojary, A., Ayoade, F., Fasciana, T., Giammanco, A., Caskurlu, H., Rajani, D. P., Gupta, Y. K., Balkan, I. I., Khan, E. A., & Erdem, H.
- Affiliations
- Bhailal Amin General Hospital (IN)
- Department of Infectious Diseases & Clinical Microbiology, Istanbul Medeniyet University, Faculty of Medicine, Istanbul 34734, Turkey
- Royal Hospital (OM)
- VM Medical Park, Pendik Hospital, Istanbul 34899, Turkey
- Breach Candy Hospital (IN)
- University of Miami (US)
- University of Palermo (IT)
- Microcare Laboratory & TRC, Surat 395003, India
- Fortis Escorts Hospital (IN)
- Cerrahpaşa Medical School, Istanbul University, Cerrahpaşa 34096, Turkey
- Shifa Tameer-e-Millat University (PK)
- King Hamad University Hospital (BH)
- Corresponding author
- Erdem, Hakan
- ORCID
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2021-10-19
- Volume
- 7
- Issue
- 10
- Pages
- 878
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC8539607
- OpenAlex
- W3205359653
- Cited by
- 56
- References
- 24
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 9 · 2023: 9 · 2022: 11
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, candidiasis, nosocomial infections, intensive care unit, risk factors, echinocandins, antifungal therapy, source control, mortality, infection control, contact precautions, antifungal resistance, azole resistance, amphotericin B resistance, central venous catheters, diabetes mellitus, renal failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

